Back to Compagnie Lombard Odier SCmA Compagnie Lombard Odier SCmA

NTLANTLA
20 quarters

Position history for Compagnie Lombard Odier SCmACompagnie Lombard Odier SCmA's holdings in INTELLIA THERAPEUTICS INC

No. Compagnie Lombard Odier SCmA exited its NTLA (Intellia Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 3,000 shares worth $94,860. Compagnie Lombard Odier SCmA already held NTLA in its Q1 2019 13F, the earliest on record, and held it in 19 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$137,000

Total Shares Change

-8,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q4
Latest
Exited
0
-100.0%
$00.0%$30.49
0
2023-Q3
Unchanged
3,000
0.0%
$94,8600.0%$31.62
0
2023-Q2
Increased
3,000
+100.0%
$122,3400.0%$40.78
36
2023-Q1
Unchanged
1,500
0.0%
$55,9050.0%$37.27
0
2022-Q4
Unchanged
1,500
0.0%
$52,0000.0%$34.89
0
2022-Q3
Decreased
1,500
-23.1%
$84,0000.0%$55.96
0
2022-Q2
Unchanged
1,950
0.0%
$101,0000.0%$51.76
0
2022-Q1
Increased
1,950
+30.0%
$142,0000.0%$72.67
28
2021-Q4
Unchanged
1,500
0.0%
$177,0000.0%$118.24
0
2021-Q3
Decreased
1,500
-50.0%
$201,0000.0%$134.15
0
2021-Q2
Decreased
3,000
-99.0%
$486,0000.0%$161.91
0
2021-Q1
Increased
285,520
+4658.7%
$22.9M0.5%$80.26
65
2020-Q4
Decreased
6,000
-40.0%
$326,0000.0%$54.40
0
2020-Q3
Unchanged
10,000
0.0%
$199,0000.0%$19.88
0
2020-Q2
Unchanged
10,000
0.0%
$210,0000.0%$21.02
0
2020-Q1
Unchanged
10,000
0.0%
$122,0000.0%$12.23
0
2019-Q4
Increased
10,000
+25.0%
$147,0000.0%$14.67
27
2019-Q3
Unchanged
8,000
0.0%
$107,0000.0%$13.35
0
2019-Q2
Unchanged
8,000
0.0%
$131,0000.0%$16.37
0
2019-Q1
First report
8,000
-
$137,0000.0%$17.08
0

Other major holders of NTLA: ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used